Survival in pancreatic carcinoma based on tumor size

Pancreas

Volumn 36, Issue 1, 2008, Pages

  Agarwal, Banke ^a   Correa, Arlene M ^b   Ho, Linus ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Endoscopic ultrasound; Pancreatic adenocarcinoma; Survival

Indexed keywords

NONIONIC CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS CARCINOMA; PANCREAS RESECTION; PRIORITY JOURNAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; ENDOSONOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38149071758     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/mpa.0b013e31814de421     Document Type: Article

References (30)

1. Bouvet M, Gamagami RA, Gilpin EA, et al. Factors influencing survival after resection for periampullary tumors. Am J Surg. 2000;180:13-17.
2. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of pancreas. Ann Surg. 1995;221:721-733.
3. Nitecki SS, Sarr MG, Colby TV, et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Ann Surg. 1995;223:59-66.
4. McNulty NJ, Francis IR, Platt JF, et al. Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature and pancreatic adenocarcinoma. Radiology. 2001;220:97-102.
5. Fletcher JG, Wiersema MJ, Farrell MA, et al. Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology. 2003;229:81-90.
6. Mertz HR, Sechopoulos P, Delbeke D, et al. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc. 2000;52:367-371.
7. Lin F, Staerkel G. Cytologic criteria for well differentiated adenocarcinoma of the pancreas in the fine needle aspiration biopsy specimens. Cancer Cytopathol. 2003;99:44-90.
8. Catalano MF, Sivak MV Jr, Rice T, et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40:442-446.
9. Fortner JG, Klimstra DS, Senie RT, et al. Tumor size is the primary prognosticator of pancreatic cancer after regional pancreatectomy. Ann Surg. 1996;223:147-153.
10. Gangi S, Fletcher JG, Nathan MA, et al. Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. Am J Radiol. 2004;182:897-903.
11. Kim JE, Lee KT, Lee JK, et al. Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol. 2004;19:182-186.
12. Homma T, Tsuchiya R. The study of the mass screening of persons without symptoms and screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in Japan, using CA19-9 and elastase or ultrasonography. Int J Pancreatol. 1991;9:119-124.
13. Canto MI, Goggins M, Yeo CJ, et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol. 2004;2:606-621.
14. Rulyak SJ, Kimmey MB, Veenstra DL, et al. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc. 2003;57:23-29.
15. Ogawa Y, Tanaka M, Inoue K, et al. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. Cancer. 2000;94:2344-2349.
16. Chari ST, Leibson CL, Rabe KG, et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology. 2005;129:504-511.
17. Tanaka M. Important clues to the diagnosis of pancreatic cancer. Rocz Akad Med Bialymst. 2005;50:69-72.
18. Fras I, Litin EM, Bartholomew LG. Mental symptoms as an aid in the early diagnosis of carcinoma of the pancreas. Gastroenterology. 1968;55:191-198.
19. Carney CP, Jones L, Woolson RF, et al. Relationship between depression and pancreatic cancer in general population. Psychosom Med. 2003;65:884-888.
20. Agarwal B, Abu-Hamda E, Molke KL, et al. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol. 2004;99:1258-1266.
21. Bipat S, Phoa SS, van Delden OM, et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr. 2005;29:438-445.
22. Eloubeidi MA, Chen VK, Eltoum IA, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol. 2003;98:2663-2668.
23. Shin HJ, Lahoti S, Sneige N. Endoscopic ultrasound-guided fine-needle aspiration in 179 cases: the MD Anderson Cancer Center experience. Cancer. 2002;96:174-180.
24. Massucco P, Capussotti L, Magnino A, et al. Pancreatic resections after chemotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Ann Surg Oncol. 2006;13:1201-1208.
25. Mimeault M, Brand RE, Sasson AA, et al. Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies. Pancreas. 2005;31:301-316.
26. Simeone DM, Ji B, Banerjee M, et al. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas. 2007;34:436-443.
27. Ehmann M, Felix K, Hartmann D, et al. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas. 2007;34:205-214.
28. Sawabu N, Watanabe H, Yamaguchi Y, et al. Serum tumor markers and molecular biological diagnosis in pancreatic cancer. Pancreas. 2004;28:263-267.
29. Saisho H, Yamaguchi T. Diagnostic imaging for pancreatic cancer: computed tomography, magnetic resonance imaging, and positron emission tomography. Pancreas. 2004;28:273-278.
30. Adler DG, Jacobson BC, Davila RE, et al. ASGE guideline: complications of EUS. Gastrointest Endosc. 2005;61:8-12.